MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 58 filers reported holding MIRATI THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,394,229 | +26.7% | 192,705 | +5.1% | 0.00% | +100.0% |
| Q2 2023 | $6,624,977 | +4.7% | 183,365 | +7.7% | 0.00% | 0.0% |
| Q1 2023 | $6,330,423 | -17.3% | 170,264 | +0.8% | 0.00% | -50.0% |
| Q4 2022 | $7,655,392 | -37.4% | 168,956 | -3.6% | 0.00% | -33.3% |
| Q3 2022 | $12,238,000 | -71.6% | 175,203 | -72.7% | 0.00% | -70.0% |
| Q2 2022 | $43,118,000 | +231.3% | 642,293 | +305.8% | 0.01% | +233.3% |
| Q1 2022 | $13,014,000 | -47.3% | 158,279 | -5.9% | 0.00% | -25.0% |
| Q4 2021 | $24,684,000 | -13.0% | 168,280 | +4.9% | 0.00% | -33.3% |
| Q3 2021 | $28,374,000 | -3.8% | 160,394 | -12.1% | 0.01% | 0.0% |
| Q2 2021 | $29,482,000 | +7.9% | 182,514 | +14.4% | 0.01% | 0.0% |
| Q1 2021 | $27,322,000 | -35.7% | 159,494 | -17.6% | 0.01% | -33.3% |
| Q4 2020 | $42,510,000 | +64.4% | 193,546 | +24.3% | 0.01% | +50.0% |
| Q3 2020 | $25,865,000 | +52.5% | 155,759 | +4.8% | 0.01% | +20.0% |
| Q2 2020 | $16,966,000 | +77.7% | 148,600 | +19.6% | 0.01% | +66.7% |
| Q1 2020 | $9,548,000 | -40.4% | 124,207 | -0.1% | 0.00% | -25.0% |
| Q4 2019 | $16,025,000 | +73.4% | 124,363 | +4.9% | 0.00% | +33.3% |
| Q3 2019 | $9,239,000 | -28.9% | 118,596 | -6.1% | 0.00% | -25.0% |
| Q2 2019 | $13,003,000 | +58.2% | 126,242 | +12.6% | 0.00% | +100.0% |
| Q1 2019 | $8,218,000 | +100.4% | 112,120 | +16.0% | 0.00% | +100.0% |
| Q4 2018 | $4,100,000 | -18.9% | 96,660 | -9.9% | 0.00% | 0.0% |
| Q3 2018 | $5,054,000 | -6.9% | 107,316 | -2.6% | 0.00% | 0.0% |
| Q2 2018 | $5,430,000 | +621.1% | 110,138 | +348.8% | 0.00% | – |
| Q1 2018 | $753,000 | +133.1% | 24,543 | +38.7% | 0.00% | – |
| Q4 2017 | $323,000 | +73.7% | 17,696 | +11.1% | 0.00% | – |
| Q3 2017 | $186,000 | +244.4% | 15,935 | +8.0% | 0.00% | – |
| Q2 2017 | $54,000 | -83.5% | 14,749 | -76.6% | 0.00% | – |
| Q1 2017 | $328,000 | +34.4% | 63,004 | +22.9% | 0.00% | – |
| Q4 2016 | $244,000 | -32.0% | 51,251 | -5.6% | 0.00% | – |
| Q3 2016 | $359,000 | +8.1% | 54,294 | -10.8% | 0.00% | – |
| Q2 2016 | $332,000 | -74.6% | 60,872 | -0.4% | 0.00% | – |
| Q1 2016 | $1,307,000 | -26.2% | 61,103 | +9.1% | 0.00% | -100.0% |
| Q4 2015 | $1,771,000 | -9.8% | 56,028 | -1.8% | 0.00% | 0.0% |
| Q3 2015 | $1,963,000 | +77.3% | 57,051 | +62.2% | 0.00% | – |
| Q2 2015 | $1,107,000 | +66.2% | 35,166 | +54.8% | 0.00% | – |
| Q1 2015 | $666,000 | +74.3% | 22,718 | +10.2% | 0.00% | – |
| Q4 2014 | $382,000 | +3.2% | 20,624 | -2.4% | 0.00% | – |
| Q3 2014 | $370,000 | -56.4% | 21,141 | -50.1% | 0.00% | – |
| Q2 2014 | $848,000 | – | 42,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |